NCT02039401View on ClinicalTrials.gov

Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 11, 2014

Primary Completion Date

August 3, 2015

Study Completion Date

March 6, 2024

Conditions
Amyotrophic Lateral Sclerosis
Interventions
BIOLOGICAL

VM202

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors
lead

Helixmith Co., Ltd.

INDUSTRY

NCT02039401 - Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis | Biotech Hunter | Biotech Hunter